Table I.

Candidate miRNAs indicate changes in arm selection preferences in lung cancer tissues compared with normal tissues.

A, Upregulated miRNAs
	5p/3p ratio fold change (tumor/normal)
miRNAs	Lung squamous cell carcinoma (LUSC)	Lung adenocarcinoma (LUAD)
hsa-mir-9-1	9.2	10.9
hsa-mir-9-2	7.0	14.6
hsa-mir-17	2.7	1.9
hsa-mir-27b	1.8	1.6
hsa-mir-29a	2.5	4.5
hsa-mir-30c-1	2.5	4.7
hsa-mir-30c-2	6.3	8.7
hsa-mir-30e	1.9	2.1
hsa-mir-33a	3.0	9.0
hsa-mir-33b	2.0	14.4
hsa-mir-96	19.8	69.5
hsa-mir-101-1	1.6	2.2
hsa-mir-125b-2	2.0	4.4
hsa-mir-127	2.2	4.5
hsa-mir-130a	1.9	1.9
hsa-mir-136	3.3	2.2
hsa-mir-140	2.1	1.9
hsa-mir-143	3.7	3.2
hsa-mir-149	3.2	3.5
hsa-mir-182	11.2	38.8
hsa-mir-205	8.7	11.3
hsa-mir-218-1	1.8	2.1
hsa-mir-224	4.3	2.4
hsa-mir-324	1.5	2.2
hsa-mir-337	2.0	4.9
hsa-mir-362	2.0	2.9
hsa-mir-425	2.0	1.8
hsa-mir-502	2.1	1.6
hsa-mir-556	3.0	5.4
hsa-mir-616	1.7	5.2
hsa-mir-671	4.3	3.4
hsa-mir-877	5.0	3.0
hsa-mir-2277	1.9	11.1
hsa-mir-3065	2.2	1.7
hsa-mir-3607	1.8	23.6
hsa-mir-3679	6.7	8.6
B, Downregulated miRNAs
	5p/3p ratio fold change (tumor/normal)
miRNAs	Lung squamous cell carcinoma (LUSC)	Lung squamous cell carcinoma (LUSC)
hsa-let-7a-3	0.6	0.6
hsa-let-7g	0.5	0.1
hsa-mir-20a	0.5	0.7
hsa-mir-26a	0.5	0.7
hsa-mir-27a	0.3	0.4
hsa-mir-29b	0.5	0.1
hsa-mir-138	0.3	0.5
hsa-mir-142	0.6	0.3
hsa-mir-335	0.7	0.5
hsa-mir-374b	0.7	0.6
hsa-mir-423	0.6	0.3
hsa-mir-455	0.2	0.4
hsa-mir-497	0.3	0.7
hsa-mir-509	0.6	0.3
hsa-mir-532	0.5	0.5
hsa-mir-589	0.4	0.6
hsa-mir-629	0.3	0.4
hsa-mir-744	0.3	0.2
hsa-mir-769	0.6	0.4

miR, microRNA.